Hepatoma Research

OCT 9, 2026 · JOURNAL ARTICLE

Gut microbiota in hepatocellular carcinoma: pathogenic mechanisms and clinical translation

Hepatoma Research

The gut microbiota is an important modulator of host metabolism and immunity. In hepatocellular carcinoma (HCC), the most common form of primary liver cancer, dysbiosis, impaired i

SEP 16, 2026 · JOURNAL ARTICLE

Chronic hepatitis C and metabolic dysfunction-associated steatotic liver disease: converging pathobiology, hepatocarcinogenesis, and clinical implications in the post-SVR era

Hepatoma Research

Against the background of the growing global burden of obesity and metabolic disease, metabolic dysfunction-associated steatotic liver disease (MASLD) has emerged as a leading caus

AUG 11, 2026 · JOURNAL ARTICLE

Pharmacological chemoprevention of hepatocellular carcinoma: hype, hope, or reality?

Hepatoma Research

A narrative expert review synthesizing current evidence on pharmacological HCC chemoprevention, identifying established approaches (antivirals, vaccination), agents with observational support (statins), and emerging candidates requiring prospective validation.